ALLERGAN recalls Viokace (pancrelipase) tablets, 20,880 USP units, 100-count bottle, Rx only, Distributed by; Allergan USA Inc., Irvine,

Recalled January 17, 2018 · FDA recall D-0154-2018 · ALLERGAN

Hazard

Subpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile. · FDA Class II

Units

12,699 bottles

Sold at

U.S.A. nationwide

Description

Subpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile.

Product

Viokace (pancrelipase) tablets, 20,880 USP units, 100-count bottle, Rx only, Distributed by; Allergan USA Inc., Irvine, CA 92612, Manufactured in Canada, NDC 58914-117-10

Manufacturer(s)

ALLERGAN

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →